|Contents||Vial: Tyr-hGH Fragment 177-191 lyophilised powder 2mg.
Ampoule: 2ml Sterile water for injection.
|Administration||Intramuscular or Subcutaneous injection.|
|Storage||Store at room temperature away from heat and direct sunlight pre reconstitution. Refrigerate between 2-8’C post Reconstitution.|
|Dosage||Initial: 5 mcg/kg/day empty stomach. May increase dose gradually. Max: 12 mcg/kg/day.|
|Contraindications||Acute critical illness due to heart or abdominal surgery, multiple accidental trauma or respiratory failure; active neoplasms, proliferative or pre-proliferative diabetic retinopathy; lactation; patients with closed epiphyses. Intracranial lesions. Patients with Prader-Willi syndrome who are severely obese or have a severe respiratory impairment.|
|Special Precautions||DM; may require dose reduction in insulin. Pregnancy. Discontinue treatment if there is evidence of tumor growth. Monitoring in patients with scoliosis is recommended due to a risk of progression of scoliosis.|
|Adverse Drug Reactions||Side effects noted are tiredness, feeling of lethargy, head rush or euphoria, itching. Loss of glycaemic control in diabetics.|
|Drug Interactions||High doses of corticosteroid may inhibit growth-promoting effects of HGH Fragment 177-191|